Curable. Inc. (XKON: 086460)
3,730.00
+460.00 (14.07%)
Sep 10, 2024, 9:00 AM KST
Curable. Company Description
Curable. Inc. provides single nucleotide polymorphism (SNP) research and analysis services in South Korea. The company offers various services, such as genome analyzer; and sequencing and re-sequencing, immunoprecipitate sequencing, small RNA discovery and analysis, and digital gene expression profiling services.
It also provides SNP genotyping services; SNP discovery services; and microsatellites typing, DNA sequencing, bio-informatics, gene identification, and statistical analysis services.
The company serves pharmaceutical companies. The company was formerly known as SNP Genetics Inc. Curable.
Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.
Curable. Inc.
Country | South Korea |
Founded | 2000 |
Industry | Commercial Physical and Biological Research |
Employees | 16 |
CEO | Hyoung-Doo Shin |
Contact Details
Address: 93 Dongtan-daero 23-gil Hwaseong-si South Korea | |
Phone | 82 31 376 1671 |
Website | curablent.com |
Stock Details
Ticker Symbol | 086460 |
Exchange | Korea New Exchange |
Reporting Currency | KRW |
SIC Code | 8731 |
Key Executives
Name | Position |
---|---|
Hyoung-Doo Shin | Chief Executive Officer |